Tokyo, Japan

Koutaro Ishibashi

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sanford Burnham Prebys Medical Discovery Institute, Daiichi Sankyo Company, Limited. Active years: 2024-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Koutaro Ishibashi. Retrieved from https://idiyas.com/inventor/koutaro-ishibashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.3

ph-index = 1


Company Filing History:


Years Active: 2024-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Koutaro Ishibashi: Innovator in Biaryl Derivatives

Introduction

Koutaro Ishibashi is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmacology, particularly through his innovative work on biaryl derivatives. His research focuses on compounds that exhibit excellent tissue non-specific alkaline phosphatase inhibitory activity.

Latest Patents

Koutaro Ishibashi holds a patent for a biaryl derivative, which is a compound or a pharmacologically acceptable salt thereof. This invention is represented by a specific formula that includes various substituents, such as nitrogen atoms, C-C alkyl groups, and halogen atoms. The compound aims to provide therapeutic benefits by inhibiting alkaline phosphatase activity.

Career Highlights

Throughout his career, Koutaro Ishibashi has worked with prominent organizations, including Daiichi Sankyo Company, Limited and Sanford Burnham Prebys Medical Discovery Institute. His work in these institutions has allowed him to advance his research and contribute to the development of new pharmacological compounds.

Collaborations

Koutaro Ishibashi has collaborated with esteemed colleagues such as Takashi Tsuji and Yasunobu Kurosaki. These partnerships have fostered a collaborative environment that enhances innovation and research in the field of pharmacology.

Conclusion

Koutaro Ishibashi's contributions to the field of biaryl derivatives highlight his role as an innovator in pharmacology. His patent and collaborations reflect his commitment to advancing medical science and improving therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…